RegMedNet, part of Taylor & Francis and based in London, delivers authoritative news and insights on regenerative medicine, cell, and gene therapy. In partnership with Regen Med, it serves a specialized audience with expert content, maintaining an engaged following of over 4,400. The platform stands as a key source for developments in regenerative medicine.

‌